CFB
TMDX icon

Cullen/Frost Bankers’s Transmedics TMDX Stock Holding History

Cullen/Frost Bankers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26
Closed -$4.08K – 1446
2024
Q3 		$4.08K Buy
+26
New +$4.01K ﹤0.01% 1030

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cullen/Frost Bankers's TMDX Position: Q4 2024 in Review

Cullen/Frost Bankers sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 26 shares — an estimated $4.08K sold.

Cullen/Frost Bankers first reported a position in TMDX in Q3 2024 and held it in 1 quarter. The position peaked at $4.08K in Q3 2024. 314 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Cullen/Frost Bankers reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Cullen/Frost Bankers sold 26 Transmedics shares in Q4 2024, an estimated $4.08K.
  • Cullen/Frost Bankers first reported a position in Transmedics in Q3 2024 and held it in 1 quarter.
  • Cullen/Frost Bankers's Transmedics position peaked at $4.08K in Q3 2024.
  • 314 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Cullen/Frost Bankers's 13F filing for Q4 2024, filed 6 Feb 2025.